Geri
Anthera Pharmaceuticals Inc (ANTH) Kazanmak
ANTH Hisse Senedi Fiyat Grafiği
ANTH Kazanmak
Anthera Pharmaceuticals Inc
$0
0%
$0
Kapanışta: Mar 24, 16:00:00 GMT-4
$0
0%
$0
Sonrası Piyasa: Mar 24, 20:00:00 GMT-4
Henüz Veri YokEarnings FAQ
ANTH'ün son EPS'si beklentilerle karşılaştırıldığında nasıldı?
Anthera Pharmaceuticals Inc ANTH'ün son çeyrekteki geliri nasıl performans gösterdi?
Anthera Pharmaceuticals Inc'in gelir tahmini nedir?
Anthera Pharmaceuticals Inc'in kazanç kalite puanı nedir?
Anthera Pharmaceuticals Inc kazançlarını ne zaman rapor eder?
Anthera Pharmaceuticals Inc'in beklenen kazançları nelerdir?
Anthera Pharmaceuticals Inc kazanç beklentilerini aştı mı?
Önemli İstatistikler
Önceki Kapanış
$0.0001
Açılış fiyatı
$0.0001
Günün Aralığı
$0.0001 - $0.0001
52 haftalık aralık
$0.0001 - $0.001
İşlem hacmi
23.8K
Ort.Hacim
991
Dividend yield
--
EPS (TTM)
-1.63
Piyasa Değeri
$2.6K
ANTH nedir?
Anthera Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines to treat serious and life-threatening diseases. The company is headquartered in Hayward, California and currently employs 21 full-time employees. The company went IPO on 2010-03-02. The firm has two Phase III product candidates, liprotamase also known as Sollpura and blisibimod. Sollpura is a non-porcine investigational Pancreatic Enzyme Replacement Therapy (PERT) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (EPI), often seen in patients with cystic fibrosis and other conditions. Blisibimod targets B-cell activating factor (BAFF), which has been shown to be elevated in a range of B-cell mediated autoimmune diseases, including systemic lupus erythematosus (SLE), or lupus, Immunoglobulin A nephropathy (IgA) nephropathy, lupus nephritis and others.
Özellikler
Kaynaklar
© 2026 Finture Development Limited. Tüm hakları saklıdır.